deuterated mitragynine (KUR-101)
/ AtaiBeckley, Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 14, 2022
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=60 | Completed | Sponsor: Kures, Inc. | Recruiting ➔ Completed
Trial completion • Pain
March 15, 2022
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=58 | Recruiting | Sponsor: Kures, Inc. | Not yet recruiting ➔ Recruiting | Trial completion date: Jun 2022 ➔ Oct 2022
Enrollment open • Trial completion date • Pain
1 to 2
Of
2
Go to page
1